Zobrazeno 1 - 10 of 150 pro vyhledávání: '"Goss SL"'
1
Akademický článek
Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
Autor: Goss SL; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois. Electronic address: sandra.goss@abbvie.com., Klein CE; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois., Jin Z; Department of Data and Statistical Sciences, AbbVie Inc, North Chicago, Illinois., Locke CS; Department of Data and Statistical Sciences, AbbVie Inc, North Chicago, Illinois., Rodila RC; Department of Bioanalysis, AbbVie Inc, North Chicago, Illinois., Kupper H; Department of Immunology Development, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany., Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-University Medicine, Berlin, Germany., Awni WM; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois.
Publikováno v: Clinical therapeutics [Clin Ther] 2018 Feb; Vol. 40 (2), pp. 309-319.
Zobrazit plný text záznamu
2
Akademický článek
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab.
Autor: Burmester GR; Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany., Kaeley GS; Department of Rheumatology, University of Florida College of Medicine, Jacksonville, Florida, USA., Kavanaugh AF; Division of Rheumatology, Allergy and Immunology, University of California San Diego, San Diego, California, USA., Gabay C; Department of Rheumatology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland., MacCarter DK; North Valley Hospital, Whitefish, Montana, USA., Nash P; Department of Medicine, University of Queensland, Brisbane, Queensland, Australia., Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University, Tokyo, Japan., Goss SL; AbbVie, North Chicago, Illinois, USA., Rodila R; AbbVie, North Chicago, Illinois, USA., Chen K; AbbVie, North Chicago, Illinois, USA., Kupper H; AbbVie Deutschland, Ludwigshafen, Germany., Kalabic J; AbbVie Deutschland, Ludwigshafen, Germany.
Publikováno v: RMD open [RMD Open] 2017 Sep 17; Vol. 3 (2), pp. e000465. Date of Electronic Publication: 2017 Sep 17 (Print Publication: 2017).
Zobrazit plný text záznamu
3
Akademický článek
Physiologically based radiopharmacokinetic (PBRPK) modeling to simulate and analyze radiopharmaceutical therapies: studies of non-linearities, multi-bolus injections, and albumin binding.
Autor: Fele-Paranj, Ali1,2 (AUTHOR), Saboury, Babak3 (AUTHOR), Uribe, Carlos2,4,5 (AUTHOR), Rahmim, Arman1,2,5 (AUTHOR) arman.rahmim@ubc.ca
Publikováno v: EJNMMI Radiopharmacy & Chemistry. 1/22/2024, Vol. 9 Issue 1, p1-17. 17p.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial.
Autor: Kaeley GS; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG. Gurjit.Kaeley@jax.ufl.edu., Evangelisto AM; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Nishio MJ; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Goss SL; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Liu S; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Kalabic J; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG., Kupper H; From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois, USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen, Germany.G.S. Kaeley, MBBS, MRCP, University of Florida College of Medicine; A.M. Evangelisto, MD, Arthritis, Rheumatic and Back Disease Associates; M.J. Nishio, MD, Diablo Clinical Research; S.L. Goss, PhD, AbbVie Inc.; S. Liu, PhD, AbbVie Inc.; J. Kalabic, MD, AbbVie Inc.; H. Kupper, MD, AbbVie Deutschland GmbH and Co. KG.
Publikováno v: The Journal of rheumatology [J Rheumatol] 2016 Aug; Vol. 43 (8), pp. 1480-9. Date of Electronic Publication: 2016 Jun 15.
Zobrazit plný text záznamu
6
Akademický článek
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial.
Autor: Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA., Kupper H; AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany., Arulmani U; AbbVie Inc, North Chicago, Illinois, USA., Florentinus S; AbbVie, Rungis, France., Goss SL; AbbVie Inc, North Chicago, Illinois, USA., Rathmann SS; AbbVie Inc, North Chicago, Illinois, USA., Fleischmann RM; University of Texas Southwestern, Dallas, Texas, USA.
Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2015 Jun; Vol. 74 (6), pp. 1037-44. Date of Electronic Publication: 2014 Feb 18.
Zobrazit plný text záznamu
8
Akademický článek
Methotrexate polyglutamates.
Autor: Yang, Zhilin, Mo, Jiayi, Li, Wenshu, Zhao, Zhigang, Mei, Shenghui
Publikováno v: Expert Review of Clinical Pharmacology; Nov2024, Vol. 17 Issue 11, p1025-1037, 13p
Zobrazit plný text záznamu
9
Editorial & Opinion
Response to H Zeidler's comments on the CONCERTO study.
Autor: Burmester GR; Charité-University Medicine Berlin, Berlin, Germany., Kivitz A; Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA., Kupper H; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany., Arulmani U; AbbVie Inc., North Chicago, Illinois, USA., Florentinus S; AbbVie, Rungis, France., Goss SL; AbbVie Inc., North Chicago, Illinois, USA., Rathmann SS; AbbVie Inc., North Chicago, Illinois, USA., Fleischmann RM; University of Texas Southwestern, Dallas, Texas, USA.
Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2014 Aug; Vol. 73 (8), pp. e51. Date of Electronic Publication: 2014 Jun 09.
Zobrazit plný text záznamu
10
Akademický článek
Effect of Ritonavir on (99m)Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIs.
Autor: Pfeifer ND; University of North Carolina at Chapel Hill, Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA., Goss SL, Swift B, Ghibellini G, Ivanovic M, Heizer WD, Gangarosa LM, Brouwer KL
Publikováno v: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2013 Jan 02; Vol. 2, pp. e20. Date of Electronic Publication: 2013 Jan 02.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje